Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C799821-100 100 µg $511 
NDUFB11 Antibody - Western blot analysis of extracts. (10ug) from 5 different cell lines and 4 human tissue by using anti-NDUFB11 monoclonal antibody. (1: Hela; 2: HepG2; 3: K562; 4: Mcf7; 5: SVT2; 6: Liver; 7: Testis; 8: Brain; 9: Uterus) at 1:200 dilution.
NDUFB11 Antibody - HEK293T cells were transfected with the pCMV6-ENTRY control. (Left lane) or pCMV6-ENTRY NDUFB11. (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates. (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NDUFB11.
NDUFB11 Antibody - Western blot analysis of extracts. (10ug) from 5 different cell lines and 4 human tissue by using anti-NDUFB11 monoclonal antibody. (1: Hela; 2: HepG2; 3: K562; 4: Mcf7; 5: SVT2; 6: Liver; 7: Testis; 8: Brain; 9: Uterus) at 1:200 dilution.
NDUFB11 Antibody - HEK293T cells were transfected with the pCMV6-ENTRY control. (Left lane) or pCMV6-ENTRY NDUFB11. (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates. (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NDUFB11.
1 of 2
2 of 2

Monoclonal Mouse anti‑Human NDUFB11 Antibody (clone OTI8C5, Carrier‑free, aa30‑163, WB) LS‑C799821

Monoclonal Mouse anti‑Human NDUFB11 Antibody (clone OTI8C5, Carrier‑free, aa30‑163, WB) LS‑C799821

Antibody:
NDUFB11 Mouse anti-Human Monoclonal (aa30-163) (Carrier-free) (OTI8C5) Antibody
Application:
WB
Reactivity:
Human
Format:
Unconjugated, Carrier-free
Other formats:
Price
Catalog Number
$511
LS-C799821-100
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
NDUFB11 Mouse anti-Human Monoclonal (aa30-163) (Carrier-free) (OTI8C5) Antibody
Application:
WB
Reactivity:
Human
Format:
Unconjugated, Carrier-free
Other formats:

Specifications

Description
NDUFB11 antibody LS-C799821 is an unconjugated mouse monoclonal antibody to human NDUFB11 (aa30-163). Validated for WB.
Target
Human NDUFB11
Synonyms
NDUFB11 | Complex I NP17.3 subunit | CI-ESSS | Np15 | NP17.3 | Neuronal protein 17.3 | Complex I-ESSS | ESSS | p17.3
Host
Mouse
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG1 Monoclonal
Clone
OTI8C5
Conjugations
Unconjugated
Purification
Affinity chromatography
Modifications
Carrier-free. Also available Unmodified.
Immunogen
Human recombinant protein fragment corresponding to amino acids 30-163 of human NDUFB11(NP_061929) produced in E.coli.
Epitope
aa30-163
Applications
  • Western blot (1:2000)
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.3, 8% Trehalose
Reconstitution
Reconstitute with PBS pH 7.3. To use this carrier-free antibody for conjugation experiment, we strongly recommend you to perform another round of desalting process.
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About NDUFB11
Q9NX14 NM_019056 NP_061929.2

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/30/2024